CENPVL3
gene geneOn this page
Summary
CENPVL3 (centromere protein V like 3, HGNC:43880) is a protein-coding gene on chromosome Xp11.22, encoding Centromere protein V-like protein 3 (A0A0U1RRI6).
Predicted to enable carbon-sulfur lyase activity and metal ion binding activity.
Source: NCBI Gene 347549 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 6 total
- MANE Select transcript:
NM_001355276
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43880 |
| Approved symbol | CENPVL3 |
| Name | centromere protein V like 3 |
| Location | Xp11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000224109 |
| Ensembl biotype | protein_coding |
| Entrez | 347549 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000417339
RefSeq mRNA: 1 — MANE Select: NM_001355276
NM_001355276
CCDS: CCDS87743
Canonical transcript exons
ENST00000417339 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001769247 | 51617020 | 51618912 |
Expression profiles
Bgee: expression breadth broad, 49 present calls, max score 73.25.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0598 / max 6.3577, expressed in 23 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 199307 | 0.0598 | 23 |
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 73.25 | gold quality |
| nucleus accumbens | UBERON:0001882 | 69.55 | gold quality |
| hypothalamus | UBERON:0001898 | 69.35 | gold quality |
| ganglionic eminence | UBERON:0004023 | 64.99 | gold quality |
| right testis | UBERON:0004534 | 62.47 | gold quality |
| testis | UBERON:0000473 | 60.61 | gold quality |
| left testis | UBERON:0004533 | 60.35 | gold quality |
| prefrontal cortex | UBERON:0000451 | 60.34 | gold quality |
| temporal lobe | UBERON:0001871 | 59.85 | gold quality |
| amygdala | UBERON:0001876 | 59.75 | gold quality |
| caudate nucleus | UBERON:0001873 | 59.24 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 58.62 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 58.43 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 58.22 | gold quality |
| putamen | UBERON:0001874 | 57.52 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 56.45 | gold quality |
| cerebral cortex | UBERON:0000956 | 56.27 | gold quality |
| frontal cortex | UBERON:0001870 | 56.20 | gold quality |
| Ammon’s horn | UBERON:0001954 | 55.92 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 55.42 | gold quality |
| duodenum | UBERON:0002114 | 54.44 | gold quality |
| brain | UBERON:0000955 | 52.75 | gold quality |
| cortical plate | UBERON:0005343 | 52.33 | gold quality |
| substantia nigra | UBERON:0002038 | 52.20 | gold quality |
| right frontal lobe | UBERON:0002810 | 49.81 | gold quality |
| primary visual cortex | UBERON:0002436 | 49.79 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 46.36 | gold quality |
| adenohypophysis | UBERON:0002196 | 43.96 | gold quality |
| pituitary gland | UBERON:0000007 | 38.66 | gold quality |
| sural nerve | UBERON:0015488 | 38.17 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.54 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cenpv | ENSDARG00000092285 |
| caenorhabditis_elegans | WBGENE00017771 |
Paralogs (3): CENPV (ENSG00000166582), CENPVL1 (ENSG00000223591), CENPVL2 (ENSG00000283093)
Protein
Protein identifiers
Centromere protein V-like protein 3 — A0A0U1RRI6 (reviewed: A0A0U1RRI6)
Alternative names: Centromere protein V pseudogene 3
All UniProt accessions (1): A0A0U1RRI6
UniProt curated annotations — full annotation on UniProt →
Cofactor. Binds 2 Zn(2+) ions per subunit.
Similarity. Belongs to the Gfa family.
RefSeq proteins (1): NP_001342205* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006913 | CENP-V/GFA | Domain |
| IPR011057 | Mss4-like_sf | Homologous_superfamily |
| IPR052355 | CENP-V-like | Family |
Pfam: PF04828
UniProt features (14 total): binding site 7, region of interest 3, compositionally biased region 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A0U1RRI6-F1 | 73.03 | 0.42 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (7): 159; 162; 201; 204; 137; 139; 157
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 5 (showing top):
GOMF_CARBON_SULFUR_LYASE_ACTIVITY, chrXp11, MEBARKI_HCC_PROGENITOR_WNT_UP, MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD, GOMF_LYASE_ACTIVITY
GO Biological Process (0):
GO Molecular Function (2): carbon-sulfur lyase activity (GO:0016846), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| lyase activity | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
52 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CENPVL3 | CDCA3 | Q99618 | 247 |
| CENPVL3 | MEI4 | A8MW99 | 245 |
| CENPVL3 | CENPQ | Q7L2Z9 | 242 |
| CENPVL3 | CBX1 | P23197 | 213 |
| CENPVL3 | ADORA2B | P29275 | 206 |
| CENPVL3 | SAXO4 | Q7Z5V6 | 203 |
| CENPVL3 | CCDC181 | Q5TID7 | 203 |
| CENPVL3 | HORMAD1 | Q86X24 | 183 |
| CENPVL3 | RAD1 | O60671 | 166 |
| CENPVL3 | ERGIC1 | Q969X5 | 166 |
| CENPVL3 | CBX5 | P45973 | 159 |
| CENPVL3 | ADORA2A | P29274 | 155 |
| CENPVL3 | CPN1 | P15169 | 154 |
| CENPVL3 | ECHDC3 | Q96DC8 | 154 |
| CENPVL3 | HORMAD2 | Q8N7B1 | 154 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0U1RR11, A0A0U1RRI6, A6NCS6, A6NJG2, B0BN44, D3YXK1, E9PY61, E9Q0B3, F5H4A9, O00220, O00221, P09038, P0DPI3, P22083, P98077, Q08AU9, Q2M2W7, Q2M3V2, Q2TBI2, Q5F267, Q5FW56, Q5IS69, Q5R866, Q5T4W7, Q5TM52, Q5U4P2, Q5VTJ3, Q659K9, Q673H1, Q69ZB3, Q6AYE8, Q6IPT2, Q6PJ61, Q7RTU4, Q7TSX9, Q7YR31, Q80SU3, Q86SH2, Q86Y97, Q8NBR0
Diamond homologs: A0A0U1RR11, A0A0U1RRI6, E1VBT6, P0DPI3, Q7Z7K6, Q9CXS4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
6 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
157 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:51618749:TGG:T | donor_gain | 0.8000 |
| X:51618384:T:TA | donor_gain | 0.6900 |
| X:51618706:T:A | donor_gain | 0.6900 |
| X:51618252:TCTG:T | donor_gain | 0.6500 |
| X:51618253:CTGC:C | donor_gain | 0.6500 |
| X:51618222:C:CT | acceptor_gain | 0.6200 |
| X:51618329:C:CA | donor_gain | 0.6200 |
| X:51618712:C:CT | donor_gain | 0.6000 |
| X:51618161:T:TA | donor_gain | 0.5800 |
| X:51618552:T:A | donor_gain | 0.5700 |
| X:51618296:G:C | acceptor_gain | 0.5200 |
| X:51618439:C:CT | acceptor_gain | 0.5100 |
| X:51618713:C:CT | donor_gain | 0.5100 |
| X:51618200:CAG:C | acceptor_gain | 0.4800 |
| X:51618260:CCGCA:C | donor_loss | 0.4800 |
| X:51618261:CGCA:C | donor_loss | 0.4800 |
| X:51618262:GCA:G | donor_loss | 0.4800 |
| X:51618263:CA:C | donor_loss | 0.4800 |
| X:51618264:AC:A | donor_loss | 0.4800 |
| X:51618265:C:CG | donor_loss | 0.4800 |
| X:51618266:C:A | donor_loss | 0.4800 |
| X:51618196:C:CT | acceptor_gain | 0.4600 |
| X:51618265:CCTG:C | donor_gain | 0.4600 |
| X:51618693:T:TA | donor_gain | 0.4600 |
| X:51618057:A:AC | donor_gain | 0.4500 |
| X:51618058:C:CC | donor_gain | 0.4500 |
| X:51618267:T:C | donor_loss | 0.4400 |
| X:51618157:G:T | donor_gain | 0.4300 |
| X:51618202:G:GC | acceptor_gain | 0.4300 |
| X:51618268:G:A | donor_gain | 0.4300 |
AlphaMissense
1840 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:51618274:G:C | F215L | 0.997 |
| X:51618274:G:T | F215L | 0.997 |
| X:51618276:A:G | F215L | 0.997 |
| X:51618344:A:G | F192S | 0.997 |
| X:51618442:A:C | F159L | 0.997 |
| X:51618442:A:T | F159L | 0.997 |
| X:51618444:A:G | F159L | 0.997 |
| X:51618247:G:C | F224L | 0.996 |
| X:51618247:G:T | F224L | 0.996 |
| X:51618249:A:G | F224L | 0.996 |
| X:51618443:A:G | F159S | 0.995 |
| X:51618250:A:C | S223R | 0.993 |
| X:51618250:A:T | S223R | 0.993 |
| X:51618252:T:G | S223R | 0.993 |
| X:51618443:A:C | F159C | 0.993 |
| X:51618365:A:G | F185S | 0.991 |
| X:51618343:G:C | F192L | 0.990 |
| X:51618343:G:T | F192L | 0.990 |
| X:51618345:A:G | F192L | 0.990 |
| X:51618248:A:G | F224S | 0.989 |
| X:51618263:C:G | C219S | 0.988 |
| X:51618264:A:T | C219S | 0.988 |
| X:51618477:G:C | H148D | 0.987 |
| X:51618565:C:A | W118C | 0.987 |
| X:51618565:C:G | W118C | 0.987 |
| X:51618458:C:T | C154Y | 0.986 |
| X:51618212:A:T | V236D | 0.985 |
| X:51618272:C:T | C216Y | 0.985 |
| X:51618464:C:G | C152S | 0.985 |
| X:51618465:A:T | C152S | 0.985 |
dbSNP variants (sampled 300 via entrez): RS1001192050 (X:51617080 A>G), RS1002842752 (X:51616538 A>G), RS1003268772 (X:51620445 G>A), RS1006948656 (X:51619350 A>C), RS1007453011 (X:51620000 T>C), RS1011495309 (X:51620501 C>T), RS1011612168 (X:51617209 C>T), RS1011878726 (X:51620855 G>A), RS1021093355 (X:51617219 A>G), RS1021229353 (X:51617566 G>A), RS1021434084 (X:51620514 A>G), RS1021498331 (X:51620177 G>C,T), RS1025559239 (X:51620093 C>T), RS1025631414 (X:51619520 G>A), RS1029770785 (X:51617336 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.